Kwanan nan, sabon littafinmu na gwajin rigakafin cutar coronavirus da tsarin ganowa cikin sauri don rigakafin shunt da sarrafawa ya sami amincewa daga Ofishin Kimiyya da Fasaha na Xiamen.

Littafin gwajin rigakafin cutar coronavirus da sabon tsarin binciken coronavirus da tsarin ganowa yana da bangarori biyu: sabon nau'in kayan aikin rigakafin cutar coronavirus IgM (colloidal zinariya) da kayan aikin ganowa cikin sauri.A cikin novel coronavirus novel coronavirus kamuwa da cuta tsari, IgM antibody shine farkon rigakafi a cikin tsarin rigakafi na ɗan adam.Gano sabon nau'in rigakafin cutar coronavirus IgM a cikin matsanancin kamuwa da cuta yana da fa'idodin babban hankali, ganewar asali da kuma ikon tantance ko wanda ake zargi ya kamu da cutar ko a'a.Kit ɗin reagent yana ɗaukar hanyar zinari na colloidal, wanda zai iya karya ta iyakancewar fasahar gano acid nucleic data kasance ga ma'aikata da wurare, kuma yana rage lokacin ganowa.A ƙarshe, kamfanin ya haɓaka kayan aikin da ya dace da kayan aikin don tallafawa ganowa, wanda zai iya haɓaka ƙimar ganowa cikin sauri, kuma ma'auni ne mai ƙarfi don tantancewa da kuma kula da yawan jama'a na asymptomatic gabaɗaya a matakin ƙarshe na fashewa.

Novel coronavirus yanzu ya mamaye shi, kuma bala'in da ya haifar da radadin da yake haifarwa ga daukacin al'umma har yanzu yana karuwa.Yana da gaggawa don yaƙar cutar.Zai yi duk abin da kamfanin zai ƙaddamar da samfurin don taimakawa gano layin farko, da kuma ba da gudummawa ga rigakafi da shawo kan cutar.